Trial Profile
Pharmacokinetic clinical study to establish proof of concept of SMT-201
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 Oct 2015
Price :
$35
*
At a glance
- Drugs Ketorolac (Primary) ; Ketorolac (Primary)
- Indications Pain
- Focus Pharmacokinetics; Proof of concept
- 28 Oct 2015 Status changed from recruiting to completed, according to a SteadyMed media release.
- 28 Oct 2015 Results were published in a SteadyMed media release.
- 18 Aug 2015 New trial record